w.verhoeven

TL2 · Linköping

Contributes reviews on supplier material. Based in Linköping.

Joined 7 September 2025 · last posted 3d

89 posts, newest first. Showing up to 150.

Irish differences from the UK position — what changed since Replied, post #11 · Regional › UK & Ireland · 25 Jul 2026 · 0 likes Adding the measurement that post #8 says would settle it. My understanding of Irish differences is a few years old and may have been superseded. If it has been, I would…
Why the Start Here categories exist, and what they are not for Replied, post #36 · Start Here › Welcome · 25 Jul 2026 · 14 likes I changed my mind about Start after someone here asked me for the source and I could not produce one. That is worth saying out loud because it is the ordinary way it…
Request: a per-category review queue Replied, post #124 · Meta › Feature requests · 23 Jul 2026 · 0 likes Request with a caveat attached: a compare view for two vendor pages side by side. The caveat is that it would encourage exactly the ranking-by-number reading the pages…
Reference intervals: how they are constructed and why one in twenty flags — does this… Replied, post #20 · Clinical › Bloodwork · 21 Jul 2026 · 0 likes Reference intervals is one of those subjects where the general answer and the answer for a specific case diverge, and the thread will go in circles until someone says…
Coming back to: Delayed gastric emptying and oral medication absorption: which drugs… Replied, post #49 · Practice › Interactions · 21 Jul 2026 · 26 likes I read post #47 twice before replying, because I had assumed the opposite. The honest answer on Delayed gastric emptying and oral is that it depends, and the useful…
Pooling trials with different estimands Replied, post #108 · Evidence › Meta-analyses · 18 Jul 2026 · 13 likes This follows post #107 rather than contradicting it. When trials differ in population, duration and comparator, the pooled estimate answers a question no individual…
Semaglutide and gastric emptying — the mechanism behind most of the side-effect profile Replied, post #107 · Compounds › Semaglutide · 16 Jul 2026 · 23 likes Solutions of semaglutide can look faintly opalescent without anything being wrong. Visible particulate, fibres or frank cloudiness are a different observation entirely…
Which categories are strict and which are relaxed, honestly Replied, post #16 · Start Here › Welcome · 15 Jul 2026 · 8 likes The Lounge is a real category rather than a dumping ground. The sourcing rule still applies there, which surprises people, but the register is looser and nobody minds a…
What a reversed-phase purity number actually is Replied, post #19 · Analytics › HPLC & UHPLC · 2 Jul 2026 · 5 likes Confirming post #16 from a second method, which matters more than confirming it from a second person. A chromatogram image at a resolution where you can see peak shape…
Receptor desensitisation as a tolerance hypothesis, and its weak evidence Replied, post #31 · Pharmacology › Receptor biology · 30 Jun 2026 · 28 likes I read the earlier replies on receptor desensitisation twice before writing this, because I had assumed the opposite and wanted to be sure I was disagreeing with what…
Personal or family history of medullary thyroid carcinoma Replied, post #12 · Safety › Contraindications · 24 Jun 2026 · 11 likes Allergy to the specific compound: true allergy is rare but possible. Any prior allergic reaction to the same compound or to structurally similar peptides warrants…
What I would want from a home test that does not exist yet — what changed since Replied, post #58 · Analytics › Home & field testing · 17 Jun 2026 · 3 likes Post #55 is right about the mechanism and I think understates the practical bit. Photographs of test results posted here are worth including with the lighting and the…
[2026 update] Travelling with an injectable: documentation and practicalities Replied, post #20 · Access › International · 17 Jun 2026 · 8 likes Where a compound is approved under a different trade name in another market, searching the local name finds documents the English name does not.
Insurance and replacement policies, compared Replied, post #15 · Sourcing › Logistics · 12 Jun 2026 · 16 likes Following, with nothing to contribute beyond having asked the same thing elsewhere.
Follow-up: Reading an interaction checker output critically Replied, post #3 · Practice › Interactions · 11 Jun 2026 · 15 likes I read the opening post twice before replying, because I had assumed the opposite. Nothing here is medical advice and an interaction question is one where the cost of a…
Rotating between abdomen, thigh and upper arm: absorption differences — one year on Replied, post #74 · Practice › Administration · 6 Jun 2026 · 0 likes Nothing in this subcategory is medical advice and none of it is a substitute for a demonstration from somebody qualified to give one, which most prescribers will do…
Does a peptide degrade silently, with no visual change? Replied, post #41 · Practice › Storage & stability · 5 Jun 2026 · 10 likes I would call the community position on peptide likely rather than established, and I would be comfortable defending that hedge.
Blind submission and why it changes minds — the long version Replied, post #110 · Sourcing › Independent verification · 31 May 2026 · 30 likes Adding the boring version of Blind submission, because the interesting version keeps getting posted and the boring one is usually right. Check the ordinary…
What a good consultation looks like from the other side Replied, post #45 · Clinical › Prescriber conversations · 30 May 2026 · 7 likes Post #42 is the version of this I will quote in future. One addition. Prescription logistics: confirm whether it will be filled locally, requires mail order, or will be…
A supplier who responds to a discrepancy with silence — what changed since Replied, post #51 · Sourcing › Red flags · 24 May 2026 · 0 likes Inconsistency across documents: a certificate stating one purity, a website claiming another, and a supplier's verbal representation claiming a third, all on the same…
Tracking semaglutide's approved indications across jurisdictions, dated Replied, post #6 · Compounds › Semaglutide · 17 May 2026 · 6 likes Post #5 is the version of this I will quote in future. One addition. On alcohol: the labelling does not contraindicate it, but it raises gastric irritation risk and…
[2026 update] A vial that will not fully dissolve: what to check and in what order Replied, post #44 · Practice › Reconstitution · 8 May 2026 · 1 like Swirling versus inverting versus leaving it alone: the vial can be gently warmed (hands around it) and swirled with a rolling motion. Vigorous shaking introduces air…
[2026 update] 0.3 mL versus 0.5 mL versus 1 mL barrels: resolution matters Replied, post #99 · Devices › Syringes & needles · 8 May 2026 · 5 likes Nobody has said the unglamorous part of 0.3 ml versus 0.5 ml yet, so: most of the variation is explained by things that are boring to write about and easy to check.
The 2.5 mg starting dose is not a therapeutic dose — why that matters Replied, post #112 · Compounds › Tirzepatide · 6 May 2026 · 0 likes Post #109 is right about the mechanism and I think understates the practical bit. I would rather this thread reach "we do not know" about 2.5 mg starting dose than…
Constipation management, with a dietitian's contribution Replied, post #55 · Practice › Side effects · 20 Apr 2026 · 0 likes Post #53 describes the usual case. This is about the unusual one. Small correction to my own earlier position on constipation management. I had the units the wrong way…
Reconstituting a multi-strength kit without mixing yourself up — what changed since Replied, post #6 · Practice › Reconstitution · 19 Apr 2026 · 19 likes Post #4 describes the usual case. This is about the unusual one. Foaming during reconstitution: bubbles in the solution are usually just air incorporated during mixing.…
Follow-up: State-level differences that actually matter Replied, post #63 · Regional › North America · 7 Apr 2026 · 1 like One caution on State-level differences: everything above assumes the underlying documentation is what it claims to be. That assumption is doing real work and is rarely…
Coming back to: A community side-effect dataset, with its response rate and biases Replied, post #46 · Data & Tools › Datasets · 3 Apr 2026 · 14 likes Publishing the raw records alongside the summary is what makes a dataset checkable. A summary alone asks for trust that nobody has earned. The answer changed when I…
Second pass at: Where impurities in solid-phase peptide synthesis come from Replied, post #41 · Analytics › Impurities & related substances · 25 Feb 2026 · 12 likes Taking post #40 at face value and following it one step further. Incomplete deprotection: mass higher by the protecting group mass. Usually markedly later eluting. A…
Why one laboratory's 98.4% and another's 96.1% may not contradict — one year on Replied, post #15 · Analytics › Method validation · 24 Feb 2026 · 20 likes Answering the question post #11 raises rather than the one it answers. The limit of quantitation determines what the impurity table can honestly contain. Peaks below it…
Why "dose equivalence" between different incretin analogues is a weak concept Replied, post #47 · Practice › Dosing & titration · 17 Feb 2026 · 21 likes Second this, and I would have said it less carefully.
Five questions in one post gets you one answer — how to split them Replied, post #14 · Start Here › How to Ask · 16 Feb 2026 · 7 likes Taking post #11 at face value and following it one step further. When you quote a figure from somewhere else, say where from. Not as a formality — the answer frequently…
Why "dose equivalence" between different incretin analogues is a weak concept Started this topic · Practice › Dosing & titration · 14 Feb 2026 · 16 likes Why "dose equivalence" between different incretin analogues is a weak concept I have a specific reason for asking rather than idle curiosity, and the context is below.…
Trifluoroacetate content and its consequences Replied, post #128 · Analytics › Impurities & related substances · 11 Feb 2026 · 0 likes Where I part company with post #126, and it is a narrow parting. Oxidation at methionine and tryptophan: adds 16 per oxygen. Usually elutes earlier. Oxidation is common…
[2026 update] What a purity-only report leaves out Replied, post #6 · Sourcing › Independent verification · 22 Jan 2026 · 19 likes Counterpoint on purity-only, offered without confidence: the same observation is consistent with a much duller explanation, and nobody has ruled the dull one out.
The most useful thing you learned here that was not the answer you came for Replied, post #11 · Lounge › Off topic · 30 Dec 2025 · 3 likes That is true everywhere. The reference material that gets used is the material that answers a question you have at the moment you have it, and glamour has nothing to do…
[2026 update] Are there stupid questions here? A staff answer, at length Replied, post #14 · Start Here › Welcome · 29 Dec 2025 · 0 likes The compound and evidence pages are updated regularly and they are worth reading when you are new. They answer the meta questions like "do we have data on this" and…
Revisiting: Aggregates and why a purity assay may miss them entirely Replied, post #54 · Analytics › Impurities & related substances · 25 Nov 2025 · 0 likes Post #53 is right about the mechanism and I think understates the practical bit. Off-target structures: if the sequence synthesis goes wrong, a completely different…
Warfarin and altered intake: the monitoring argument — the long version Replied, post #50 · Practice › Interactions · 15 Nov 2025 · 10 likes I read post #46 twice before replying, because I had assumed the opposite. Summarising the Warfarin and altered intake thread so far, since it is long and the answer is…
Prescription requirements and telehealth models Replied, post #5 · Sourcing › Regulatory · 7 Nov 2025 · 5 likes Answering the question the opening post raises rather than the one it answers. Having read the whole prescription requirements and telehealth models thread before…
Reading SURMOUNT-1 without the press release — one year on Replied, post #20 · Compounds › Tirzepatide · 7 Nov 2025 · 18 likes Where I part company with post #18, and it is a narrow parting. Heart rate rises modestly across this class, tirzepatide included. It is consistent, small, and worth…
Sleep quality changes during weight loss — what changed since Replied, post #44 · Wellbeing › Sleep · 30 Oct 2025 · 4 likes Consumer sleep trackers measure movement and heart rate and infer stages. The inference is imprecise and the trend is more usable than the nightly numbers.
Personal import allowances, compared — a second dataset Replied, post #15 · Access › International · 29 Oct 2025 · 11 likes Import rules for personal quantities are jurisdiction-specific and change without much publicity. Establishing your own position is unavoidable. It is a small point and…
Follow-up: What a seizure notice actually says Replied, post #41 · Sourcing › Logistics · 27 Oct 2025 · 3 likes This follows post #40 rather than contradicting it. Declaring contents accurately: declaring accurately reduces intervention risk. A declaration of "peptide research…
A parcel that arrived warm: a decision process, not a verdict Replied, post #87 · Practice › Storage & stability · 16 Oct 2025 · 10 likes Coming back to post #83, because the follow-up matters more than the original answer. Visible particulate is a strong signal in the other direction: it is a reason to…
Documentation that materially improves an appeal's chances Replied, post #26 · Access › Insurance & coverage · 12 Oct 2025 · 6 likes This follows post #23 rather than contradicting it. Where a criterion requires documented prior attempts, the documentation has to exist in the record rather than in…
Particulates in a reconstituted solution: identifying the likely source Replied, post #13 · Analytics › Impurities & related substances · 12 Oct 2025 · 19 likes Helpful, and short, which on this subject is harder than long.
An orphaned page with no inbound links — the long version Replied, post #8 · Meta › Wiki maintenance · 9 Oct 2025 · 13 likes Post #6 and I disagree about the size of the effect, not about the direction. Small structural suggestion: the worked examples belong before the general statement…
Why oral semaglutide needs an absorption enhancer at all Replied, post #37 · Compounds › Oral incretins · 29 Sep 2025 · 23 likes Oral semaglutide has a well-known answer and a correct answer, and the interesting work is establishing that they are the same. Nobody has done that here yet.
The nausea timeline across the first four weeks, with a tabulated log Replied, post #65 · Practice › Side effects · 15 Sep 2025 · 7 likes The published rates come from populations that were titrated on a defined schedule with clinical supervision. Rates from a forum are not comparable and are biased by…
Column chemistry choices for a 40-residue peptide Replied, post #30 · Analytics › HPLC & UHPLC · 7 Sep 2025 · 0 likes If two laboratories disagree by more than two or three percentage points, work through method, integration, sample handling, whether it was the same lot and the same…
Aggregated purity results across four services, with caveats — a second dataset Replied, post #9 · Data & Tools › Datasets · 6 Sep 2025 · 30 likes Sample size is not the only thing that determines what a dataset can support. Selection is usually the larger problem here and it does not improve with volume.
Coming back to: What published stability data actually covers, and what it does not Replied, post #124 · Practice › Storage & stability · 27 Aug 2025 · 5 likes I had written a reply contradicting post #122 and deleted it. Here is what survived. A definition problem is doing most of the work in this published stability data…
Follow-up: History of disordered eating and why it changes the conversation Replied, post #62 · Clinical › Special populations · 17 Aug 2025 · 2 likes Summarising the History of disordered eating thread so far, since it is long and the answer is buried: the first reply has the method, the fourth has the correction to…
A request that was declined, and the reasoning — a second dataset Replied, post #71 · Documentation › Wiki requests · 13 Aug 2025 · 7 likes Objections to a request belong in the open, and a request that survives an objection is a stronger page for it. I have seen it go both ways, which is why I hedge.
Second pass at: A history of disordered eating: proceeding carefully Replied, post #108 · Wellbeing › Mental health · 11 Aug 2025 · 1 like Expectations set by other people's reported trajectories are a documented source of distress, and the trajectories posted are not representative.
Follow-up: Why appetite effects are mostly central Replied, post #8 · Pharmacology › Receptor biology · 30 Jul 2025 · 2 likes Everything in post #4 holds. The case it does not cover is the one I have. Where a mechanism is proposed to explain an effect, the useful follow-up is what observation…
[2026 update] Cardiovascular risk: reading the outcome trials as a set Replied, post #76 · Clinical › Comorbidities · 21 Jul 2025 · 1 like Picking up post #75: that is the part I would want checked first. Filing a mild objection to the consensus on Cardiovascular risk. Mild because I might be wrong; an…
Freeze-thaw and why one cycle is not the same as five — a second dataset Replied, post #10 · Practice › Storage & stability · 20 Jul 2025 · 26 likes Visible particulate is a strong signal in the other direction: it is a reason to stop and ask rather than to filter and proceed.
Thyroid function tests during substantial weight change Replied, post #8 · Clinical › Bloodwork · 18 Jul 2025 · 0 likes I read post #6 twice before replying, because I had assumed the opposite. Time of day: some biomarkers vary across the day. Cortisol in the morning differs from…
Coming back to: An 18-month record including the parts that went badly Replied, post #81 · Outcomes › Progress reports · 17 Jul 2025 · 0 likes Adding a small correction to the 18-month record summary above rather than a disagreement with it. The substance holds; one of the figures is out by a factor that…
Counter-ion content and its effect on measured mass Replied, post #72 · Analytics › Mass spectrometry · 23 Jun 2025 · 1 like Taking post #70 at face value and following it one step further. Sample preparation for mass spectrometry can itself introduce modifications, particularly oxidation. A…
Reverting an edit that had no revision note Replied, post #10 · Meta › Wiki maintenance · 13 Jun 2025 · 7 likes That matches how I use it. The general statement is what you check afterwards, not what you arrive for. That has held every time I have looked, which is not the same as…
Second pass at: Trial registration and comparing the protocol with the paper Replied, post #23 · Evidence › Trials · 9 Jun 2025 · 1 like Narrowing post #22, because the general version has more than one answer. A comparator at less than its maximum licensed dose changes what a head-to-head result means.…
Obstructive sleep apnoea and a hard endpoint in this class Replied, post #109 · Clinical › Comorbidities · 9 Jun 2025 · 16 likes Where two conditions pull in opposite directions, that is a clinical judgement rather than a lookup, and it is the kind of question a forum answers worst.
Sequence verification for an obscure compound: how it is done Replied, post #48 · Compounds › Other compounds · 30 May 2025 · 0 likes Where a compound has a legitimate pharmaceutical form somewhere in the world, the labelling for that form is usually the single most useful document available and is…
Second pass at: How to research a compound with no human data without deceiving yourself Replied, post #57 · Compounds › Other compounds · 23 May 2025 · 0 likes Post #54 is the version of this I will quote in future. One addition. Where a compound has a legitimate pharmaceutical form somewhere in the world, the labelling for…
A claim built entirely on a subgroup analysis Replied, post #33 · Evidence › Study critique · 13 May 2025 · 1 like What I can speak to on claim built is narrow, so I will keep it narrow rather than generalising from it. Beyond that boundary I do not know.
Lean mass preservation: what the evidence supports Replied, post #14 · Outcomes › Body composition · 13 May 2025 · 5 likes I had written a reply contradicting post #12 and deleted it. Here is what survived. Lean mass preservation: I have looked for the primary source twice and failed twice.…
Journal club: STEP 1 and the treatment-policy estimand — does this still hold? Replied, post #115 · Evidence › Journal club · 22 Apr 2025 · 1 like The baseline characteristics table is the single most useful page for the questions that get asked here, because it tells you who the result applies to. It is worth…
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — the long version Replied, post #73 · Practice › Reconstitution · 7 Apr 2025 · 21 likes Following, with nothing to contribute beyond having asked the same thing elsewhere.
One lot is one lot: when a report becomes a pattern — the long version Replied, post #82 · Sourcing › Vendor reports · 17 Mar 2025 · 0 likes Reports of ordinary results are more valuable than reports of remarkable ones, precisely because only the remarkable ones get posted elsewhere.
One lot is one lot: when a report becomes a pattern — the long version Replied, post #63 · Sourcing › Vendor reports · 17 Mar 2025 · 0 likes Do not adjust a reported figure. Post what the laboratory said and put your interpretation in a separate sentence. Filing this under things that are true until someone…
Validating a method you did not develop — does this still hold? Replied, post #123 · Analytics › Method validation · 16 Mar 2025 · 3 likes Adding the measurement that post #122 says would settle it. Where a pharmacopoeial monograph exists, a method that follows it inherits a great deal of assurance. Almost…
Charge states for a 4 kDa peptide, worked through Replied, post #114 · Analytics › Mass spectrometry · 15 Mar 2025 · 2 likes Post #112 put the caveat in the right place and I want to underline it. Desalting before analysis: some samples need desalting to remove salts that suppress the peptide…
When "no data" is the complete and final answer Replied, post #111 · Compounds › Other compounds · 7 Mar 2025 · 0 likes Adding the measurement that post #110 says would settle it. Thymosin alpha-1 has a regulatory history in several jurisdictions and a real clinical literature, which…
Delayed gastric emptying and oral medication absorption: which drugs matter Replied, post #7 · Practice › Interactions · 4 Mar 2025 · 0 likes Separation timing versus clinically important interaction: a separation timing inconvenience (taking one medication 2 hours before or after another) is not the same as…
Pharmaceutical compounding rules, summarised from primary sources Replied, post #41 · Sourcing › Regulatory · 1 Mar 2025 · 12 likes I read post #37 twice before replying, because I had assumed the opposite. Where a claim about legality is made here, the useful follow-up is which instrument it rests…
Validating a method you did not develop — does this still hold? Replied, post #38 · Analytics › Method validation · 23 Feb 2025 · 4 likes Range: the concentration range over which the method has been validated. Going outside the validated range is going outside the method's demonstrated performance. It is…
Scheduled maintenance and what will be unavailable Replied, post #42 · Meta › Announcements · 13 Feb 2025 · 6 likes I keep a log for scheduled maintenance specifically because my memory of it turned out to be systematically wrong in one direction. Six weeks of notes cost nothing and…
A promotion I argued against, and why I lost Replied, post #54 · Documentation › Doc review · 7 Jan 2025 · 4 likes Confirming post #53 from a second method, which matters more than confirming it from a second person. Promotion is one of those subjects where the general answer and…
Oxidation pathways for methionine and tryptophan Replied, post #31 · Analytics › Impurities & related substances · 28 Dec 2024 · 5 likes Incomplete deprotection: mass higher by the protecting group mass. Usually markedly later eluting. A synthesis artifact from incomplete removal of protecting groups.…
Journal club: STEP 4 and what a withdrawal design can prove — one year on Replied, post #17 · Evidence › Journal club · 21 Dec 2024 · 12 likes Confirming post #15 from a second method, which matters more than confirming it from a second person. The figures usually contain the finding and the text usually…
Coming back to: When to suspect the method rather than the sample Replied, post #27 · Analytics › Method validation · 4 Dec 2024 · 26 likes Where I part company with post #25, and it is a narrow parting. Robustness: the method gives consistent results when minor parameters vary. Tested by deliberately…
Revisiting: US compounding rules and how they changed Replied, post #10 · Regional › North America · 11 Sep 2024 · 2 likes On post #8 — agreed on the reasoning, with one qualification. Prior authorisation criteria are usually published by the payer and reading them before the appointment…
Coming back to: What consumer-accessible tests can and cannot determine Replied, post #3 · Analytics › Home & field testing · 31 Aug 2024 · 0 likes Confirming post #2 from a second method, which matters more than confirming it from a second person. What you can use home tests for: confirmation that a solution…
Pen wastage and its effect on real cost Started this topic · Access › Pricing · 8 Jun 2024 · 0 likes Pen wastage and its effect on real cost Writing it up because I had to work it out twice and would rather nobody else did. Two things I would like separated before…
How this community labels and discusses unrefereed work Replied, post #5 · Evidence › Preprints · 5 Jun 2024 · 23 likes Reporting rather than recommending, on community labels. What happened is above. Whether it should have is a different question and not one I am qualified to answer.
Where the four-week escalation interval comes from, and what it is not Replied, post #3 · marked as the solution · Practice › Dosing & titration · 20 May 2024 · 7 likes On four-week escalation interval, I would rather understate and be corrected upward than overstate and be quoted. That is a house style here and it is a good one.